|
Abbott India Limited - Company Profile Snapshot
| Supplementary Analyses Reports |
| Financial Statement Analysis |
| Balance Sheet & Income Statement: |
| Common Size |
| Year To Year Percent Change |
| 5 Year Averages |
| Sources Of Capital |
| Financial Ratio Analysis |
| Accounting Ratios |
| Asset Utilization |
| Employee Efficiency |
| Fixed Charges Coverage |
| Leverage Analysis |
| Liquidity Analysis |
| Per Share Data |
| Profitability Analysis |
| Wright Quality Rating |
| Investment Acceptance |
| Financial Strength |
| Profitability & Stability |
| Corporate Growth |
 View sample Supplementary Analyses (PDF)
|
| Company Profile: |
Abbott India Limited |
| Ticker: |
500488 |
| Exchanges: |
BOM |
| 2007 Sales: |
5,943,200,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
INDIA |
| Employees: |
1042 |
Business Description
Abbott India Limited. The Company's principal activities are to develop, manufacture and market pharmaceutical, diagnostic, nutritional and hospital products. These products are in the form of tablets, liquids, ointments and injectables. Other pharmaceutical preparations include insulin, basic drugs and other related products. The Company's brand names include Brufen, Digene, Insulin, Prothiaden, Froben FR, Cremaffin and Eptoin. The Company operates only in India.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
